Lert 135 mg Ampoule
PDF Leaflet Revision Date: 03 November 2022
Clinical Summary
Quick overview from the medicine insert
Indication
To help maintain wakefulness and increased mental activity.
Dosage (summary)
Adults: 1-2 tablets, then 1 tablet every 3 hours if needed.
Special Populations
- Caution in hyperacidity
- Peptic ulcer history
- Porphyria
- Hyperthyroidism
- Hypertension
- Cardiac arrhythmias
Pregnancy & Breastfeeding
Safety in pregnancy/lactation not established; caffeine appears in breast milk.
Key Drug Interactions
- Allopurinol
- Cimetidine
- Oral contraceptives
- Ritonavir
- Rifampicin
Contraindications
- Hypersensitivity to caffeine
- Cardiac disease
- Kidney disease
- Epilepsy
Common side effects
- Insomnia
- Headache
- Nervousness
- Tachycardia
- Nausea
Counselling Points
- Avoid use in children under 12
- Monitor for irritability in infants if breastfeeding
- Report adverse reactions
Serious warnings
- Caution advised when driving or operating machinery
- Potential for tolerance and dependency
Important Disclaimer
The Lert 135 mg Ampoule professional information leaflet below is the property of Lebasi Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
